Literature DB >> 9526588

AgNOR counts and their combination with flow cytometric analyses and clinical parameters as a prognostic indicator in breast carcinoma.

J Rzymowska1.   

Abstract

Silver binding nucleolar organizer regions (AgNORs) were counted in tissue sections and were shown to assist in the distinction between benign and malignant breast lesions. The mean AgNOR counts in fibroadenomas were 1.05 +/- 0.85 (n = 18), in lobular carcinoma 3.55 +/- 0.56 (n = 35), and in intraductal carcinoma 4.83 +/- 1.20 (n = 45). AgNOR counting may provide information on breast cancer prognosis supplementary to that obtained with other methods such as flow cytometric analysis. The AgNOR values in carcinomas were also compared with ploidy and S-phase fractions (S) by flow cytometry. More than 75% of the total cancers with counts above 3 dots per nuclear profile contained aneuploid cells, whereas 20% with counts below 3 contained diploid cells (P < 0.05). Similar trends were noticed with regard to S-phase fractions, which were 45% +/- 12.5 and 14% +/- 4.5, respectively, for the two groups (P < 0.05). AgNOR counting, flow cytometry and clinical parameters may provide complementary information on breast cancer prognosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9526588     DOI: 10.1177/030089169708300613

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  RNA polymerase III transcripts and the PTB protein are essential for the integrity of the perinucleolar compartment.

Authors:  Chen Wang; Joan C Politz; Thoru Pederson; Sui Huang
Journal:  Mol Biol Cell       Date:  2003-06       Impact factor: 4.138

2.  Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation.

Authors:  Sandra A S Johnson; Louis Dubeau; Deborah L Johnson
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

3.  Association between AgNORs and Immunohistochemical Expression of ER, PR, HER2/neu, and p53 in Breast Carcinoma.

Authors:  Hussain Gadelkarim Ahmed; Mohammed Ali Al-Adhraei; Ibraheem M Ashankyty
Journal:  Patholog Res Int       Date:  2011-11-01

4.  Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?

Authors:  A Elzagheid; T Kuopio; S Pyrhönen; Y Collan
Journal:  Diagn Pathol       Date:  2006-11-08       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.